BIOLASE Inc. (BIOL)

1.38
NASDAQ : Health Technology
Prev Close 1.38
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.14 / 6.00
Avg Volume 127.00K
Exchange NASDAQ
Shares Outstanding 20.48M
Market Cap 23.96M
EPS -1.40
Div & Yield N.A. (N.A)

Latest News

BIOLASE Secures $6 Million Revolving Line Of Credit

BIOLASE Secures $6 Million Revolving Line Of Credit

Will Help Fund Future Growth as Company Moves Toward Achieving Positive Operating Cash Flow and Profitability Goals

BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device

BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device

Innovative ClearView SCAN™ Device: Dentistry's First Intra-oral Ultrasound Diagnostic Imaging

BIOLASE Announces Initiatives To Increase Dental Laser Awareness And Education In Southern California

BIOLASE Announces Initiatives To Increase Dental Laser Awareness And Education In Southern California

Company adding field support specialists, educational courses, a SoCal advisory board and other initiatives to help dentists deliver the highest level of patient care and build thriving practices

BIOLASE Receives Awards From Leading Industry Organizations For Its Dental Laser Systems

BIOLASE Receives Awards From Leading Industry Organizations For Its Dental Laser Systems

Recognized by Dentaltown for the best hard tissue laser, Dr. Bicuspid for the best new dental product, and Dentistry Today by listing the premier soft-tissue laser as a Top 50 Technology Product

BIOLASE Announces Expiration Of Rights Offering

BIOLASE Announces Expiration Of Rights Offering

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the subscription period for its previously announced rights offering to holders of shares of its common stock expired at 5:00 p.

BIOLASE To Conduct Demos Of Portable Waterlase Express™ All-Tissue Laser System At Greater New York Dental Meeting

BIOLASE To Conduct Demos Of Portable Waterlase Express™ All-Tissue Laser System At Greater New York Dental Meeting

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be conducting demonstrations of its recently launched Waterlase Express all-tissue laser system at the Greater New York Dental...

BIOLASE To Present At The Singular Research Best Of The Uncovered 12th Annual Conference 2017

BIOLASE To Present At The Singular Research Best Of The Uncovered 12th Annual Conference 2017

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it is scheduled to present at the Singular Research Best of the Uncovered 12th Annual Conference 2017 on Monday, December 4, 2017, at...

BIOLASE Announces Commencement Of Rights Offering

BIOLASE Announces Commencement Of Rights Offering

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has commenced its previously announced rights offering to holders of shares of its common stock.

BIOLASE Announces Terms Of Rights Offering

BIOLASE Announces Terms Of Rights Offering

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the terms of its previously announced rights offering to holders of shares of its common stock.

BIOLASE Reports 2017 Third Quarter And Nine-Month Results

BIOLASE Reports 2017 Third Quarter And Nine-Month Results

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its third quarter and the nine months ended September 30, 2017.

BIOLASE Appoints Richard B. Lanman To Board Of Directors

BIOLASE Appoints Richard B. Lanman To Board Of Directors

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it has appointed Richard B.

BIOLASE Announces Record Date For Previously Announced Proposed Rights Offering

BIOLASE Announces Record Date For Previously Announced Proposed Rights Offering

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that its Board of Directors has set the record date of 5:00 p.

BIOLASE® To Host 2017 Third Quarter Financial Results Conference Call On November 1

BIOLASE® To Host 2017 Third Quarter Financial Results Conference Call On November 1

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, November 1, 2017, at 4:30 p.

BIOLASE Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

BIOLASE Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that on October 2, 2017, John R.

BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer

BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that veteran financial executive John R.

BIOLASE Announces Plans For Rights Offering To Stockholders

BIOLASE Announces Plans For Rights Offering To Stockholders

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to...

BIOLASE Names Jonathan T. Lord Chairman Of The Board

BIOLASE Names Jonathan T. Lord Chairman Of The Board

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that on September 1, 2017 it named Jonathan "Jack" T.

BIOLASE Reports 2017 Second Quarter And Six-Month Results

BIOLASE Reports 2017 Second Quarter And Six-Month Results

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its second quarter and six months ended June 30, 2017.

BIOLASE® To Host 2017 Second Quarter Financial Results Conference Call On August 7

BIOLASE® To Host 2017 Second Quarter Financial Results Conference Call On August 7

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, August 7, 2017, at 4:30 p.

BIOLASE Announces Management Change

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has accepted the resignation of recently named Chief Financial Officer Mark J.

BIOLASE Reports 2017 First Quarter Results

BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its first quarter ended March 31, 2017.

TheStreet Quant Rating: D- (Sell)